These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

805 related items for PubMed ID: 22534543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [Abstract] [Full Text] [Related]

  • 3. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
    Cao Z, Lin W, Huang Z, Chen X, Zhao J, Zheng L, Ye H, Liu Z, Liao L, Du J.
    Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
    [Abstract] [Full Text] [Related]

  • 4. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 5. FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo.
    Jin K, He K, Teng F, Li G, Wang H, Han N, Xu Z, Cao J, Wu J, Yu D, Teng L.
    Clin Transl Oncol; 2011 Dec; 13(12):878-84. PubMed ID: 22126731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L.
    Oncotarget; 2015 Dec 29; 6(42):44563-78. PubMed ID: 26575424
    [Abstract] [Full Text] [Related]

  • 10. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H, Cong Q, Du Z, Liao W, Zhang L, Yao Y, Ding K.
    Cancer Lett; 2016 Nov 01; 382(1):44-52. PubMed ID: 27569654
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
    Chen HH, Zhou HJ, Wu GD, Lou XE.
    Pharmacology; 2004 May 01; 71(1):1-9. PubMed ID: 15051917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS, Kit-Lam C, Majid AM, Al-Suede FS, Mohammed Saghir SA, Abdullah WZ, Ahamed MB, Yusoff NM.
    Microvasc Res; 2013 Nov 01; 90():30-9. PubMed ID: 23899415
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X, Wang X, Ye H, Peng A, Chen L.
    Cancer Chemother Pharmacol; 2012 Sep 01; 70(3):425-37. PubMed ID: 22814678
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.
    J Ethnopharmacol; 2012 Jun 01; 141(2):721-7. PubMed ID: 21911050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
    Zhao J, Lin W, Zhuang Q, Zhong X, Cao Z, Hong Z, Peng J.
    Integr Cancer Ther; 2014 Nov 01; 13(6):520-8. PubMed ID: 25148840
    [Abstract] [Full Text] [Related]

  • 20. Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.
    Qian X, Zhu L, Hu J, Li M, Xie L, Wang L, Yu L, Liu B.
    J Ethnopharmacol; 2012 Aug 30; 143(1):256-61. PubMed ID: 22750432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.